E-Pharmacies Boost Saudi Pharmaceutical Market Expansion

According to the latest market research study published by P&S Intelligence, the Saudi Arabian pharmaceuticals market is poised for significant growth, with projections estimating its value to reach USD 21.8 billion in 2024 and further expand at a compound annual growth rate (CAGR) of 4.5%, culminating in USD 28.3 billion by 2030. This upward trajectory is largely driven by the nation's expanding population and escalating healthcare concerns. In response, the government has been proactive in enhancing and broadening healthcare infrastructure and accessibility, thereby fueling the rapid advancement of the pharmaceutical sector.​

A notable contributor to this growth is the increasing prevalence of chronic diseases, such as respiratory disorders and diabetes, primarily attributed to lifestyle changes. For instance, the International Diabetes Federation reported that in 2021, approximately 4,272,100 out of 24,194,300 adults in Saudi Arabia were living with diabetes. These chronic conditions necessitate ongoing medication for effective treatment and management, thereby amplifying the demand for pharmaceutical products.

To Learn More About this Report

Key Insights

Product Type Analysis

• Prescription Drugs:
• In 2024, prescription drugs are anticipated to constitute 60% of the market share. This dominance is propelled by the rising incidence of chronic diseases, including ischemic heart disease, obesity, and hypertension, which require long-term medication regimens. Additionally, the presence of multinational pharmaceutical companies supplying branded medications through wholesale partners bolsters this segment.
• Over-the-Counter (OTC) Drugs:
• While prescription drugs lead in market share, OTC drugs are experiencing faster growth. This surge is linked to the availability of medications for general conditions, such as common colds and headaches, which consumers can purchase without a doctor's prescription.

Distribution Channel Analysis

• Retail Pharmacies:
• Retail pharmacies are projected to hold a 45% market share in 2024. Their adoption of modern retail practices, such as efficient inventory management, organized store layouts, and enhanced customer service, makes them increasingly appealing to consumers. Moreover, these pharmacies offer the convenience of medication refills without necessitating hospital visits.

Indication Analysis

• Cardiovascular Diseases (CVDs):
• CVDs are expected to account for the highest market revenue. A study indicates an overall CVD prevalence of 1.6% across all provinces in Saudi Arabia, with higher rates among males (1.9%) compared to females (1.4%). Furthermore, the National Library of Medicine identifies CVDs as a leading cause of mortality in the country, responsible for approximately 45.7% of deaths. The chronic nature of many CVDs necessitates long-term treatment and careful management, thereby driving demand for related medications.
• Diabetes:​
• Diabetes is identified as the fastest-growing category within the pharmaceuticals market. The substantial number of adults living with diabetes underscores the escalating demand for effective diabetic treatments and management solutions.

Regional Analysis

• Al-Riyadh:
• Al-Riyadh is leading the market with a 35% share in 2024. This prominence is attributed to its status as a central hub for major pharmaceutical companies and hospitals. The province's sophisticated logistics and cold-chain infrastructure further enhance its attractiveness for pharmaceutical distribution.
• Eastern Region:​
• The Eastern Region is projected to experience a CAGR of 4.8% during the forecast period. This growth is driven by enhancements in healthcare infrastructure and a burgeoning population, both of which contribute to increased demand for pharmaceutical products.

Technological Advancements

E-Pharmacies:​

A significant trend in the Saudi Arabian pharmaceuticals market is the growing utilization of e-pharmacies. In 2022, approximately 92% of the population owned smartphones, facilitating easy access to online medicine ordering platforms. E-pharmacies offer benefits such as convenient access, home deliveries, prescription management solutions, product information, and counseling services, thereby enhancing the consumer experience. Government support for e-commerce and digitalization further propels the growth of e-pharmacies.

Competitive Landscape

The Saudi Arabian pharmaceuticals market is characterized by high competitiveness, with several major players, including Tabuk Pharmaceuticals and Al Tadawi Healthcare, actively participating. Government initiatives promoting local companies, along with insurance and healthcare reforms, have led to an increase in the number of operating players. Intense competition among pharmaceutical companies in pricing strategies, supply chain management, and promotional campaigns further intensifies the market dynamics.

In summary, the Saudi Arabian pharmaceuticals market is on a robust growth trajectory, driven by factors such as an increasing prevalence of chronic diseases, technological advancements like e-pharmacies, and strategic government initiatives aimed at enhancing healthcare infrastructure and accessibility. The market's segmentation across product types, distribution channels, indications, and regions offers diverse opportunities for stakeholders to capitalize on emerging trends and address evolving healthcare needs.

h    107    

w    662.516

107

662.516

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Read More

Global ECG Cables Market Set for 7.3% CAGR Growth by 2030

According to the latest market research study published by P&S Intelligence, the global ECG cables and lead wires market is poised for substantial growth, with projected revenues reaching $2,009.7 million in 2024 and anticipated to climb to $3,071.7 million by 2030, reflecting a compound annual growth rate (CAGR) of 7.3% during the forecast period.

This upward trajectory is primarily driven by the increasing prevalence of cardiovascular diseases (CVDs) and a growing geriatric population worldwide. As the incidence of CVDs rises, there is an escalating demand for accurate and regular cardiac monitoring, thereby boosting the need for ECG cables and lead wires. Additionally, technological advancements, such as the integration of wireless and Bluetooth technologies into ECG devices, are enhancing patient comfort and mobility, further propelling market growth.

Key Insights

Product Segmentation

The market is segmented into ECG lead wires and ECG cables. Both segments are experiencing growth due to the rising demand for cardiac monitoring devices.

Material Usage

Thermoplastic elastomer (TPE) and thermoplastic polyurethane (TPU) are the primary materials used in manufacturing ECG cables and lead wires. These materials offer flexibility and durability, essential for patient comfort and device longevity.

Usability Types

The market caters to both reusable and disposable ECG cables and lead wires. The choice between them depends on factors like cost, infection control protocols, and hospital policies.

End-User Insights

Hospitals and clinics represent the largest end-user segment, driven by the high volume of cardiac procedures performed. Ambulatory facilities are also significant consumers, reflecting the trend towards outpatient cardiac care.

Download Free Report Sample Now

Regional Trends

North America holds the largest market share, attributed to advanced healthcare infrastructure and a high prevalence of CVDs. The Asia-Pacific region is anticipated to be the fastest-growing market, propelled by increasing healthcare investments and a rising burden of cardiovascular diseases.

Technological Advancements

The shift towards wireless and Bluetooth-enabled ECG devices is a notable trend, enhancing patient mobility and comfort. For instance, some advanced ECG monitoring systems now utilize Bluetooth-enabled ECG lead wires, allowing for seamless data transmission.

Competitive Landscape

The market is fragmented, with numerous players striving for market share. Companies are focusing on product innovation and strategic partnerships to differentiate themselves in this competitive landscape.

Emerging Opportunities

The integration of advanced technologies, such as artificial intelligence and machine learning, into ECG devices presents new growth avenues. These technologies can enhance diagnostic accuracy and offer predictive analytics, thereby improving patient outcomes.

The ECG cables and lead wires market is on a robust growth trajectory, fueled by rising cardiovascular disease prevalence, technological innovations, and expanding healthcare infrastructures globally. Stakeholders are poised to benefit from the myriad opportunities emerging in this dynamic market landscape.

Read More

Biotech Innovations Drive U.S. & EU Peptide Synthesis Growth

The custom peptide synthesis services market in the U.S. and the European Union (EU) is experiencing significant growth, driven by the escalating demand for peptides in therapeutic applications, diagnostics, and research. In the U.S., the market is projected to expand from USD 177.97 million in 2024 to USD 270.94 million by 2030, reflecting a compound annual growth rate (CAGR) of 7.8%. Similarly, the EU market is expected to grow from USD 130.76 million in 2024 to USD 203.51 million by 2030, with a CAGR of 8.2%. This upward trajectory underscores the vital role of custom peptides in addressing diseases such as cancer, infectious ailments, and metabolic disorders, aligning with the goals of personalized medicine.

Explore Insights with a Free Sample Report

Key Insights

Segmentation Analysis:

Purity Levels: The market offers peptides with varying purity levels, including up to 75%, 76–90%, and above 90%, catering to diverse research and therapeutic needs.

Applications: Custom peptides are utilized in multiple domains such as peptide therapeutics, antibody production, biomarker discovery, isotopic labeling, protein production, and cosmetics development.

Technologies: Synthesis techniques encompass Solid-Phase Peptide Synthesis (SPPS), Liquid-Phase Peptide Synthesis (LPPS), and hybrid methods, enhancing the versatility and efficiency of peptide production.

End Users: Primary consumers include pharmaceutical and biotechnology companies, research institutes, and cosmetic manufacturers, each leveraging custom peptides for specific applications.

Regional and Geographical Trends:

United States: The U.S. market is anticipated to grow at a CAGR of 7.8% between 2024 and 2030, driven by advancements in biotechnology and a robust focus on personalized medicine.

European Union: The EU market is projected to witness a CAGR of 8.2% during the same period, with Germany leading both in size and growth rate, attributed to its strong pharmaceutical sector and emphasis on research and development.

Technological Advancements Shaping the Market:

Innovations such as automated synthesizers and high-throughput methods have significantly improved the efficiency and accuracy of peptide production.

These advancements facilitate the synthesis of complex peptides, including those with post-translational modifications and non-standard amino acids, expanding the scope of peptide applications in various fields.

Competitive Dynamics, Major Players, and Emerging Opportunities:

The market is characterized by fragmentation, encompassing a diverse range of entities from large pharmaceutical and biotechnology firms to specialized peptide synthesis providers and startups.

This competitive landscape fosters innovation and offers a variety of services to meet the evolving needs of the market.

Emerging opportunities are evident in the increasing adoption of peptides in vaccine development, targeted therapies, and diagnostic assays, driven by the growing prevalence of chronic diseases and the pursuit of personalized treatment solutions.

In summary, the U.S. and EU custom peptide synthesis services market is poised for robust growth, propelled by technological innovations, diverse applications, and a dynamic competitive environment. Stakeholders are well-positioned to capitalize on the expanding opportunities within this vital sector.

Read More

High-Slice Computed Tomography Scanners Dominate Global Market

The global computed tomography (CT) market is experiencing significant growth, with a valuation of USD 6.3 billion in 2024 and an anticipated expansion to USD 11.6 billion by 2032, reflecting a compound annual growth rate (CAGR) of 8.0% during 2025–2032. This upward trajectory is primarily driven by the increasing applications of CT scanners across various medical procedures, including comprehensive imaging of the brain and body. Technological advancements and substantial government investments in countries such as India, China, and Japan are further propelling market growth.

Key Insights

Technological Advancements

Over the past decade, CT devices have seen significant technological developments, including the emergence of low-dose and automated CT scanners. These innovations offer superior image quality and enhanced spatial resolution with minimal radiation exposure. Notable advancements include iterative reconstruction technology, which provides better images at reduced radiation doses, and spectral imaging that utilizes dual energy sources for improved clarity.

Market Segmentation

·         By Type: High-slice CT scanners dominate the market, accounting for a 40% revenue share in 2024. Their superior diagnostic capabilities, such as producing clearer images with lower radiation doses, make them preferable for complex imaging procedures, including cardiovascular assessments.

·         By Application: The oncology segment leads the market, driven by increased cancer awareness and advancements in detection techniques. CT scans are extensively used to assess metastasis and provide high-clarity images vital for cancer diagnosis, staging, and treatment monitoring.

Regional Trends

·         North America: Holding a 40% revenue share in 2024, North America's dominance is attributed to the presence of key industry players and a high prevalence of chronic diseases. Continuous product innovations and a strong healthcare infrastructure further bolster the market in this region.

·         Asia-Pacific (APAC): APAC is projected to experience the highest CAGR of 8.5% during the forecast period. Factors such as the rising prevalence of cancer and cardiovascular diseases, coupled with growing healthcare investments in countries like China and India, contribute to this rapid growth.

Competitive Landscape

The CT market is fragmented, featuring a mix of established companies and emerging players. Key industry participants include GE HealthCare Technologies Inc., Siemens Healthineers, and Canon Inc., among others. These companies are actively engaging in product launches, strategic collaborations, and technological innovations to maintain a competitive edge.

In summary, the computed tomography market is poised for substantial growth, driven by technological advancements, expanding applications in medical diagnostics, and significant investments in healthcare infrastructure across various regions.

Read More

Rising Medical Errors Boost Demand for Hospital Risk Management Solutions

According to the latest market research study published by P&S Intelligence, the hospital risk management market is projected to reach USD 3,482.3 million by 2030, expanding at a CAGR of 13.5%. This surge is largely attributed to the rising frequency of medical errors and the global prevalence of chronic diseases.

Cloud-based risk management solutions accounted for over 80% of market revenue in the past and are anticipated to grow at a rate of 14% in the future. The increasing demand for interoperability across hospitals and companies, enabling seamless data exchange between databases and systems while reducing operating costs, is driving this growth. The adoption of electronic health records (EHRs), e-prescriptions, mHealth, and telehealth is further fueling industry expansion.

Leading market players are strengthening their positions through acquisitions to enhance cloud-based risk management solutions. For instance, in February 2022, IBM Corporation acquired Neudesic LLC to expand its portfolio of hybrid multi-cloud services.

Large hospitals are expected to dominate the market with a 60% share by 2030, driven by the rising number of large hospitals, increased hospital spending, and the growing use of EHRs. In the U.S., over 90% of hospitals are currently in the process of validating EHRs.

Effective hospital risk management is crucial for the smooth functioning of EHR systems, helping to minimize medical errors. Countries like Japan, South Korea, Russia, and Germany lead in hospital bed density, with ratios of 12.8, 12.4, 8.0, and 7.9 beds per 1,000 people, respectively.

North America leads the global hospital risk management market, with a strong presence of industry players in the U.S. The shift from on-premises to cloud-based healthcare IT solutions and the increasing use of data analytics to optimize hospital workflows are key growth drivers. Additionally, the rising number of medical errors contributes to market expansion. For example, approximately 10,000 Americans die each year due to medication errors, costing the U.S. around USD 40 billion annually.

The growing rate of preventable medical errors, surpassing deaths from car accidents, breast cancer, and AIDS, is expected to continue driving demand for hospital risk management solutions.

Read More

Transforming Healthcare with AI-Powered Medical Imaging

AI-based medical imaging is transforming the field of healthcare by assisting physicians in providing more efficient, personalized, and accurate diagnosis and treatment selections.

Thanks to deep learning algorithms, medical imaging equipment now allows doctors to find irregularities and discover disorders with a greater level of speed and accuracy than ever before. This is because of the substantial advancement in diagnosis precision, treatment effectiveness, and the general quality of patient care.

Over the past few years, there has been a rising acceptance of AI in the healthcare sector to enhance diagnostics, patient care, and evaluation of the patient’s medical information. The utilization of AI technology is becoming more prevalent in medical imaging. Artificial Intelligence’s goal is not to substitute radiologists but to assist them in improving the diagnostic procedure.

To learn more about this report: https://bit.ly/3XZZAfU

Understanding Medical Imaging

Simply, medical imaging refers to different technologies that are employed to observe the human body to diagnose, treat, or monitor medical conditions. It generally encompasses non-invasive picturing methods for medical personnel to recognize injuries and diagnose illnesses or chronic conditions.

The use of AI analysis in medical imaging assists doctors in identifying problem details or areas that might be missed by the human eye. For example, AI-based medical imaging can examine data points in a medical report to recognize a disease from a healthy part as well as signals from noise.

AI-powered medical imaging has been extensively utilized to:

• Recognize complicated patterns in imaging data.
• Identify image modalities at different treatment phases.
• Deliver a quantitative assessment of radiographic traits.
• Find different ailments characteristics that are not noticeable by human eyes.

Major applications of AI-based medical imaging are:

Cardiovascular Disorders

Cardiovascular disorders are generally diagnosed by assessing the patient’s heart structure. Conventionally, chest X-rays are employed first to find possible heart-associated irregularities. For instance, this technique is employed as a screening tool for an enlarged heart or cardiomegaly.

AI-powered medical imaging equipment can assist in identifying left atrial enlargement, therefore classifying a cardiac issue.

Neurological Abnormalities

AI technology has been effective in obtaining appropriate data from brain pictures. This has assisted in diagnosing different brain abnormalities.

AI-based medical imaging is also utilized to effectively diagnose neurological conditions such as amyotrophic lateral sclerosis, or ALS, and assist doctors in planning for lasting care. In addition, artificial intelligence algorithms in medical imaging can ease amyotrophic lateral sclerosis diagnosis by identifying any pictures that demonstrate suspect results.

Cancer Screening

Medical images are extensively utilized in the assessment of cancers such as colon cancer and breast cancer. For example, in breast cancer, tissue microcalcification is hard to classify as either benign or malignant. In this instance, false positives often result in unnecessary treatment, while unnoticed malignancies can delay diagnoses and affect the medical result.

AI-based medical imaging can enhance the precision and accuracy of finding microcalcifications by utilizing quantitative imaging.

In Ending This

With the surging chronic disorders incidence and the rising need for medical services for the elderly populace, the demand for AI-based medical imaging will reach USD 11,921.4 million in 2030.

Read More

Service Demand to Drive Life Science Analytics Growth

The life science analytics market is projected to expand at a CAGR of 9.6%, reaching USD 18,386 million by 2030. Key drivers for this growth include the increasing emphasis on early disease detection through data analysis, helping to understand prescription patterns and optimize treatment approaches throughout a patient’s healthcare journey, while improving operational efficiency.

The demand for services is expected to see the highest growth, fueled by the presence of major multinationals like Accenture, IBM, and Oracle, which provide a comprehensive range of services in consulting, strategy, operations, and technology. These services enable personalized healthcare and enhanced patient outcomes.

For instance, Accenture supports the life sciences industry with offerings in R&D, medical technology, patient services, supply chain management, and cloud computing. These services help reduce costs, streamline operations, and improve engagement between healthcare companies, patients, and payors.

The on-demand analytics segment will grow at a CAGR of 9.7% due to the availability of flexible solutions. These solutions help users tackle complex challenges such as adapting to regulatory changes, incorporating new technologies, reassessing portfolios, and utilizing real-world evidence for data management and analysis.

In addition, corporations are becoming more agile, reducing the time to bring vaccines from development to production. This agility greatly benefits biotech firms that have been working tirelessly to develop vaccines since the pandemic outbreak. The growth of the life science analytics market is further supported by the rapid response of IT companies providing these solutions.

The Asia-Pacific region will experience the fastest growth, with a 9.9% CAGR by 2030. Factors driving this growth include the rising incidence of chronic diseases, expanding life sciences industry, increasing adoption of advanced technologies, and a focus on strengthening their presence in emerging Asian economies. Increased investment, economic growth in India and China, and improved healthcare infrastructure further fuel the market.

Europe ranks as the second-largest market, driven by the development of new analytics applications in life sciences and the rising demand from the pharmaceutical sector. Analytics in life sciences is heavily utilized to assess clinical trial risks, enhance R&D, forecast budgets, and determine pricing strategies.

The rising global prevalence of chronic diseases will continue to drive the demand for life science analytics solutions in the coming years.

Read More

Global Market for Depyrogenated Sterile Empty Vials: Growth Trends and Regional Insights

According to the latest market research study published by P&S Intelligence, the market for depyrogenated sterile empty vials was valued at USD 3,101.8 million in 2024 and is projected to reach USD 4,521.7 million by 2030, growing at a compound annual growth rate (CAGR) of 6.5%.

This growth is driven by the rise in the number of clinical laboratories, the rapid expansion of the pharmaceutical industry, and advancements in pharmaceutical packaging technology.

In 2022, clinical laboratories represented the largest share of the market, contributing approximately 60% of the revenue. This dominance is due to the increasing number of such laboratories, particularly in India, where the population exceeds 1.4 billion and the demand for medical testing services is high. The expansion of clinical laboratories in India is further supported by government initiatives aimed at improving healthcare access.

Compounding laboratories also played a significant role in 2022, accounting for around 20% of the market share. Their importance stems from their ability to produce personalized medicines tailored to individual patient needs.

North America led the market in 2022, holding approximately 40% of the revenue share. This is attributed to the growing demand for vials in clinical and research settings, the rising prevalence of infectious diseases, and advancements in pharmaceutical packaging technology. Additionally, the increasing number of clinical laboratories in the region for diagnostic tests supports this growth.

The APAC region is expected to experience the highest CAGR in the coming years, driven by factors such as a rise in infectious diseases, enhanced screening and diagnostic technologies, and increasing antimicrobial resistance.

Europe also holds a substantial market share, largely due to the growing pharmaceutical sector across various countries. Germany stands out as a major producer of active biopharmaceutical ingredients within the EU, contributing significantly to the market.

LATAM is anticipated to see rapid growth due to factors like an increase in age-related and chronic diseases, higher healthcare spending by governments, rising investments by both multinational and local companies, and increasing income levels driving demand for quality healthcare services.

Overall, the depyrogenated sterile empty vials market is set to continue its growth trajectory due to the increasing number of clinical laboratories and the swift expansion of the global pharmaceutical sector.

Read More

Technological Advancements and Growing Demand Propel Growth in the Surgical Stapler Industry

In 2023, the surgical stapler market was valued at USD 5.3 billion. It is expected to grow at a rate of 6.9% from 2024 to 2030, reaching USD 8.4 billion by 2030. This growth is driven by the increasing preference for staplers over sutures.

Technological advancements have led several industry companies to commercialize staplers to meet the rising demand from doctors worldwide. These devices are used in various medical fields, including thoracic, gynecology, and gastrointestinal surgeries, as well as tissue and wound management procedures.

North America leads the market due to the rise in medical procedures, acceptance of advanced technologies, and the popularity of non-invasive methods. The high incidence of obesity, presence of major medical consumable companies, and regulatory approval for minimally invasive procedures contribute significantly to the region's market share. Specialized devices for thoracoscopic and laparoscopic procedures using medical staplers are now available.

Continued technological progress will drive the growth of this sector. Medical device manufacturers are developing staplers with enhanced safety features, ergonomic designs, and precision to meet evolving healthcare needs. Stapling designs are also improving with the integration of advanced imaging technologies, robotics, and AI.

The trend towards single-use sterile devices and the reduced need for cleaning, disinfecting, and maintenance should also be noted. Focusing on reducing hospital infection rates and improving patient flow in healthcare facilities will further promote industry growth.

Ambulatory surgical centers (ASCs) will become a preferred model for service delivery due to limited financial resources in developed and developing countries. ASCs offer quicker turnover and shorter waiting times, making them attractive to patients.

However, hospitals will continue to dominate the market during the forecast period. Most complex and open surgeries are performed in hospitals, as ASCs and independent clinics often lack the necessary specialists and equipment. Additionally, only large, well-funded hospitals can afford expensive medical robots, making them the primary venues for minimally invasive surgeries.

In summary, the commercialization of staplers by industry companies to meet the growing demand from doctors worldwide, driven by technological improvements, is propelling market growth.

Read More